Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Upstream Bio (UPB) Change in Accured Expenses (2023 - 2025)

Upstream Bio has reported Change in Accured Expenses over the past 3 years, most recently at $2.8 million for Q4 2025.

  • Quarterly results put Change in Accured Expenses at $2.8 million for Q4 2025, up 60.74% from a year ago — trailing twelve months through Dec 2025 was $4.0 million (up 165.48% YoY), and the annual figure for FY2025 was $4.0 million, up 165.48%.
  • Change in Accured Expenses for Q4 2025 was $2.8 million at Upstream Bio, up from -$481000.0 in the prior quarter.
  • Over the last five years, Change in Accured Expenses for UPB hit a ceiling of $3.5 million in Q2 2025 and a floor of -$1.9 million in Q1 2025.
  • Median Change in Accured Expenses over the past 3 years was $382000.0 (2024), compared with a mean of $685000.0.
  • Peak annual rise in Change in Accured Expenses hit 822.77% in 2025, while the deepest fall reached 285.71% in 2025.
  • Upstream Bio's Change in Accured Expenses stood at $639000.0 in 2023, then soared by 174.65% to $1.8 million in 2024, then soared by 60.74% to $2.8 million in 2025.
  • The last three reported values for Change in Accured Expenses were $2.8 million (Q4 2025), -$481000.0 (Q3 2025), and $3.5 million (Q2 2025) per Business Quant data.